Transferable Collective Variable to accelerate Protein-Ligand (Un)Binding Transitions via Explainable Machine Learning and Intriguing Role of Ligand Solvation

Abstract

The process of drug unbinding is of immense importance in the field of biophysics and therapeutics. The behavior of these systems is greatly influenced by their thermodynamic and kinetic properties. Therefore, it is crucial to accurately estimate the ligand binding free energies and rate of ligand dissociation, yet these processes are often governed by rare event transitions that lie beyond the reach of standard brute-force molecular dynamics simulations. While enhanced sampling simulations offer a solution, their efficacy is strictly contingent upon the selection of appropriate collective variables (CVs) which is non-trivial for complex systems like protein-ligand complexes. In this study, we present a method to derive optimized CV from transition state region (TS) via an interpretable machine learning (ML) model, Elastic Net. By employing some physically intuitive order parameters, the derived optimized CV from the TS-region greatly accelerate ligand binding-unbinding transitions and achieves rapid free energy surface (FES) convergence across diverse systems including buried and solvent exposed active sites such as Trpsin-benzamidine complex, host-guest systems and sodium epoxidase etc. Intriguingly significant contribution of the ligand hydration is found in the optimized CV which depicts crucial role of solvent in driving ligand binding-unbinding transitions. The estimated binding free energies for different protein-ligand complexes match quite well with experiments, while maintaining a low computational cost. The derived optimized CV is also used to calculate the ligand residence times across different systems and calculated residence times are within the experimental range for all systems, again with very little computational costs. Moreover, we show that the optimized CV constructed from TS region via an interpretable ML model is transferable across diverse systems, offering a robust and scalable framework for drug discovery and investigation of complex biomolecular recognition.